全文获取类型
收费全文 | 5377篇 |
免费 | 306篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 154篇 |
妇产科学 | 80篇 |
基础医学 | 757篇 |
口腔科学 | 485篇 |
临床医学 | 389篇 |
内科学 | 1159篇 |
皮肤病学 | 128篇 |
神经病学 | 530篇 |
特种医学 | 98篇 |
外科学 | 658篇 |
综合类 | 16篇 |
预防医学 | 472篇 |
眼科学 | 76篇 |
药学 | 356篇 |
中国医学 | 23篇 |
肿瘤学 | 273篇 |
出版年
2024年 | 8篇 |
2023年 | 48篇 |
2022年 | 83篇 |
2021年 | 167篇 |
2020年 | 125篇 |
2019年 | 159篇 |
2018年 | 160篇 |
2017年 | 128篇 |
2016年 | 134篇 |
2015年 | 179篇 |
2014年 | 218篇 |
2013年 | 270篇 |
2012年 | 423篇 |
2011年 | 476篇 |
2010年 | 288篇 |
2009年 | 223篇 |
2008年 | 365篇 |
2007年 | 342篇 |
2006年 | 285篇 |
2005年 | 250篇 |
2004年 | 265篇 |
2003年 | 219篇 |
2002年 | 172篇 |
2001年 | 54篇 |
2000年 | 46篇 |
1999年 | 52篇 |
1998年 | 36篇 |
1997年 | 32篇 |
1996年 | 32篇 |
1995年 | 31篇 |
1994年 | 26篇 |
1993年 | 19篇 |
1992年 | 44篇 |
1991年 | 40篇 |
1990年 | 30篇 |
1989年 | 45篇 |
1988年 | 28篇 |
1987年 | 22篇 |
1986年 | 21篇 |
1985年 | 18篇 |
1984年 | 15篇 |
1983年 | 11篇 |
1982年 | 10篇 |
1979年 | 19篇 |
1977年 | 12篇 |
1975年 | 9篇 |
1973年 | 8篇 |
1972年 | 8篇 |
1969年 | 6篇 |
1968年 | 6篇 |
排序方式: 共有5708条查询结果,搜索用时 31 毫秒
1.
2.
3.
Cost‐Effectiveness and Cost‐Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study
下载免费PDF全文
![点击此处可从《Neuromodulation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Furio Zucco MD Roberta Ciampichini MSc Angelo Lavano MD Amedeo Costantini MD Marisa De Rose MD Paolo Poli MD Gianpaolo Fortini MD Laura Demartini MD Enrico De Simone MD Valentino Menardo MD Piero Cisotto MD Mario Meglio MD Luciana Scalone PhD Lorenzo G. Mantovani DSc 《Neuromodulation》2015,18(4):266-276
4.
5.
J.L. Bernat A.M. D'Alessandro F.K. Port T.P. Bleck S.O. Heard J. Medina S.H. Rosenbaum M.A. DeVita R.S. Gaston R.M. Merion M.L. Barr W.H. Marks H. Nathan K. O'Connor D.L. Rudow A.B. Leichtman P. Schwab N.L. Ascher R.A. Metzger V. Mc Bride W. Graham D. Wagner J. Warren F.L. Delmonico 《American journal of transplantation》2006,6(2):281-291
A national conference on organ donation after cardiac death (DCD) was convened to expand the practice of DCD in the continuum of quality end-of-life care. This national conference affirmed the ethical propriety of DCD as not violating the dead donor rule. Further, by new developments not previously reported, the conference resolved controversy regarding the period of circulatory cessation that determines death and allows administration of pre-recovery pharmacologic agents, it established conditions of DCD eligibility, it presented current data regarding the successful transplantation of organs from DCD, it proposed a new framework of data reporting regarding ischemic events, it made specific recommendations to agencies and organizations to remove barriers to DCD, it brought guidance regarding organ allocation and the process of informed consent and it set an action plan to address media issues. When a consensual decision is made to withdraw life support by the attending physician and patient or by the attending physician and a family member or surrogate (particularly in an intensive care unit), a routine opportunity for DCD should be available to honor the deceased donor's wishes in every donor service area (DSA) of the United States. 相似文献
6.
Background
Due to marginalization, trafficking violence, conflicts with the police and organic and social psychological problems associated with the drug, crack is one of the most devastating drugs currently in use. However, there is evidence that some users manage to stay alive and active while using crack cocaine for many years, despite the numerous adversities and risks involved with this behavior. In this context, the aim of the present study was to identify the strategies and tactics developed by crack users to deal with the risks associated with the culture of use by examining the survival strategies employed by long-term users. 相似文献7.
Otavio A C Clark Gary H Lyman Aldemar A Castro Luciana G O Clark Benjamin Djulbegovic 《Journal of clinical oncology》2005,23(18):4198-4214
PURPOSE: Current treatment for febrile neutropenia (FN) includes hospitalization for evaluation, empiric broad-spectrum antibiotics, and other supportive care. Clinical trials have reported conflicting results when studying whether the colony-stimulating factors (CSFs) improve outcomes in patients with FN. This Cochrane Collaboration review was undertaken to further evaluate the safety and efficacy of the CSFs in patients with FN. METHODS: An exhaustive literature search was undertaken including major electronic databases (CANCERLIT, EMBASE, LILACS, MEDLINE, SCI, and the Cochrane Controlled Trials Register). All randomized controlled trials that compare CSFs plus antibiotics versus antibiotics alone for the treatment of established FN in adults and children were sought. A meta-analysis of the selected studies was performed. RESULTS: More than 8,000 references were screened, with 13 studies meeting eligibility criteria for inclusion. The overall mortality was not influenced significantly by the use of CSF (odds ratio [OR] = 0.68; 95% CI, 0.43 to 1.08; P = .1). A marginally significant result was obtained for the use of CSF in reducing infection-related mortality (OR = 0.51; 95% CI, 0.26 to 1.00; P = .05). Patients treated with CSFs had a shorter length of hospitalization (hazard ratio [HR] = 0.63; 95% CI, 0.49 to 0.82; P = .0006) and a shorter time to neutrophil recovery (HR = 0.32; 95% CI, 0.23 to 0.46; P < .00001). CONCLUSION: The use of the CSFs in patients with established FN caused by cancer chemotherapy reduces the amount of time spent in hospital and the neutrophil recovery period. The possible influence of the CSFs on infection-related mortality requires further investigation. 相似文献
8.
9.
10.